InMed Pharmaceuticals Inc. (INM) reports FY EPS of ($3.25)

InMed Pharmaceuticals Inc. (NASDAQ: INM) reported FY EPS of ($3.25). Revenue for the FY came in at $4.14 million.

For earnings history and earnings-related data on InMed Pharmaceuticals Inc. (INM) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Aon names interim CFO as Edmund Reese exits the firm
• BWS Financial Downgrades Inter Parfums (IPAR) to Sell